Progress in Medicinal Chemistry

The perceived lack of drug discovery productivity in recent times has led to much debate in the pharmaceutical/biotechnology industry as escalating R&D costs are not being matched by increased output. Few observers doubt that selecting the right targets, ie those which are critical to disease pathology and are ''druggable'', is the best starting point for improved productivity.The seven chapters o...